ClinicalTrials.Veeva

Menu
A

Atlanta Center for Medical Research | Atlanta, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lurasidone
Cariprazine
SEP-363856
Rapastinel
PF-06649751
Dasotraline
KarXT
SPD489
Bryostatin
Staccato Loxapine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

16 of 204 total trials

A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older (Engage)

The purpose of this study is to show that high-dose quadrivalent seasonal influenza vaccine (HD QIV) given together with 9-valent extraintestinal pat...

Active, not recruiting
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Biological: HD quadrivalent influenza vaccine
Biological: ExPEC9V

The goal of this study is to evaluate the safety and tolerability of MK-8189 in participants with stable bipolar I disorder. There will be no hypothe...

Enrolling
Bipolar I Disorder
Drug: MK-8189
Drug: Placebo

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling
Bipolar I Disorder
Depression
Drug: Placebo
Drug: Cariprazine

This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in d...

Active, not recruiting
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules

The purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.

Enrolling
Bipolar Disorder
Drug: Placebo
Drug: BHV-7000

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.

Invitation-only
Bipolar Disorder
Drug: BHV-7000

The purpose of this study is to evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population.

Enrolling
Schizophrenia
Drug: Placebo
Drug: Cariprazine

Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Enrolling
Treatment Resistant Depression
Drug: Psilocybin

The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.

Enrolling
Painful Lumbosacral Radiculopathy
Drug: VX-548
Drug: Placebo

The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants wit...

Enrolling
Parkinson Disease
Drug: Lu AF28996
Locations recently updated

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Enrolling
Bipolar I Disorder
Schizophrenia
Drug: Cariprazine Flexible Dose

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Enrolling
OSA
Drug: Placebo
Drug: AD109

A Phase 3, randomized, double-blind, placebo-controlled, multi-center, fixed-dose, parallel-group efficacy and safety study in a pediatric population...

Active, not recruiting
Attention Deficit Hyperactivity Disorder Combined
Attention Deficit Hyperactivity Disorder
Drug: CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Drug: CTx-1301-Dexmethylphenidate 25mg (randomized fixed dose)

To demonstrate HSK3486 0.4/0.2 mg/kg (0.4 mg/kg intravenous \[IV\] slow injection over 30 \[±5\] seconds for the first dose, an additional 0.2 mg/kg...

Enrolling
General Anesthesia
Drug: HSK3486
Drug: Propofol

This is a study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of FTX-6058 in participants with sickle cell disease.

Enrolling
Sickle Cell Anemia
Sickle Cell Disease
Drug: FTX-6058 oral capsule(s)

Autism spectrum disorder (ASD) consists of deficits in social, communication, and cognitive development, repetitive and stereotypic behaviors. Many A...

Enrolling
Autism Spectrum Disorder
Drug: Placebo
Drug: Cariprazine

Trial sponsors

Pfizer logo
Sumitomo Pharma logo
Shire logo
AbbVie logo
Janssen (J&J Innovative Medicine) logo
Otsuka logo
Allergan logo
H
Karuna Therapeutics logo
L

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems